" Quick-starting " of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition

Conditions: Ultrasound Finding: Ovulation Inhibition, Ovarian Activities; Cervical Mucus; Serum Hormonal Profile Interventions: Drug: Estetrol 15 mg/Drospirenone 3 mg (24/4); Drug: Ethinylestradiol (EE) 20 mcg/Gestodene 75 mcg (21/7) Sponsors: Chulalongkorn University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials